4.7 Article

COVID-19 Vaccine Acceptance among Liver Transplant Recipients

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Biochemistry & Molecular Biology

A global survey of potential acceptance of a COVID-19 vaccine

Jeffrey V. Lazarus et al.

Summary: Survey data from 19 countries reveals varying attitudes towards acceptance of a COVID-19 vaccine, with trust in government being linked to vaccine confidence.

NATURE MEDICINE (2021)

Article Gastroenterology & Hepatology

EASL position paper on the use of COVID-19 vaccines in patients with chronic liver diseases, hepatobiliary cancer and liver transplant recipients

Markus Cornberg et al.

Summary: According to a recent estimate by the World Health Organization, the SARS-CoV-2 pandemic has affected nearly 100 million people globally, with patients with chronic liver diseases (CLD) at higher risk of infections. Vaccination against various pathogens, including SARS-CoV-2, is important for these patients, although impaired immune responses may affect the efficacy of immunization. The safety, immunogenicity, and efficacy of SARS-CoV-2 vaccines in patients with CLD, cirrhosis, hepatobiliary cancer, and liver transplant recipients still require further study.

JOURNAL OF HEPATOLOGY (2021)

Article Immunology

Christian nationalism and COVID-19 vaccine hesitancy and uptake

Katie E. Corcoran et al.

Summary: Christian nationalism is one of the strongest predictors of COVID-19 vaccine hesitancy and is negatively associated with vaccine uptake. Understanding this relationship could have important implications for achieving herd immunity, as Christian nationalists make up approximately 20 percent of the population.

VACCINE (2021)

Article Gastroenterology & Hepatology

Low immunogenicity to SARS-CoV-2 vaccination among liver transplant recipients

Liane Rabinowich et al.

Summary: Liver transplant recipients showed significantly lower immunological response to the Pfizer-BioNTech SARS-CoV-2 mRNA-based vaccine, with less than half developing sufficient levels of antibodies and lower average antibody levels compared to healthy controls. Predictors for non-response included older age, renal function and immunosuppressive medications.

JOURNAL OF HEPATOLOGY (2021)

Article Immunology

COVID-19 Vaccine: A Survey of Hesitancy in Patients with Celiac Disease

Andrea Costantino et al.

Summary: A study found that 25.2% of Italian CD patients had hesitancy towards COVID-19 vaccines, with a 4.8% refusal rate. The main reason for hesitancy was fear of adverse events related to vaccination. Determinants positively influencing willingness to be vaccinated included adherence to a GFD, good knowledge about COVID-19 and its vaccines, and a positive attitude towards previous vaccines.

VACCINES (2021)

Article Gastroenterology & Hepatology

Italian association for the study of the liver position statement on SARS-CoV2 vaccination

Francesco Paolo Russo et al.

Summary: The vaccination campaign against Sars-CoV-2 started in Italy at the end of December 2020, initially targeting health workers and nursing home residents before expanding to the general population. While SARS-CoV2 vaccines are considered safe for the general population, there is currently no data available for patients with liver diseases or those who have undergone liver transplantation. The AISF's current position statement is based on published data on the impact of Sars-Cov-2 infection on patients with chronic liver disease, suggesting a potential vaccination priority for this group of patients.

DIGESTIVE AND LIVER DISEASE (2021)

Letter Gastroenterology & Hepatology

High acceptance rate of COVID-19 vaccination in liver transplant recipients

Edoardo G. Giannini et al.

JOURNAL OF HEPATOLOGY (2021)

Letter Public, Environmental & Occupational Health

The role of religiosity in COVID-19 vaccine hesitancy

Louiegi L. Garcia et al.

Summary: Religious beliefs can influence people's attitudes towards vaccination, becoming a factor of hesitation.

JOURNAL OF PUBLIC HEALTH (2021)

Article Medicine, General & Internal

Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase

H. M. El Sahly et al.

Summary: The mRNA-1273 vaccine demonstrated high efficacy in preventing COVID-19 illness and severe disease, with more than 5 months of protection and a good safety profile, including protection against asymptomatic infection.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Medicine, General & Internal

Association of BNT162b2 mRNA and mRNA-1273 Vaccines With COVID-19 Infection and Hospitalization Among Patients With Cirrhosis

Binu John et al.

Summary: The study shows that in cirrhosis patients who received mRNA COVID-19 vaccines, the first dose significantly reduces COVID-19 infections, while the second dose provides complete protection against hospitalization or death due to COVID-19 infection.

JAMA INTERNAL MEDICINE (2021)

Article Gastroenterology & Hepatology

Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study

Gwilym J. Webb et al.

LANCET GASTROENTEROLOGY & HEPATOLOGY (2020)

Article Biotechnology & Applied Microbiology

Information sources and knowledge on vaccination in a population from southern Italy: The ESCULAPIO project

Garden Tabacchi et al.

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2017)

Article Immunology

How to deal with vaccine hesitancy?

Juhani Eskola et al.

VACCINE (2015)

Article Immunology

Vaccine hesitancy: Definition, scope and determinants

Noni E. MacDonald

VACCINE (2015)

Article Medicine, General & Internal

New Decade of Vaccines 5 Addressing the vaccine confidence gap

Heidi J. Larson et al.

LANCET (2011)